Literature DB >> 24866500

Three commercial antibodies against α1-adrenergic receptor subtypes lack specificity in paraffin-embedded sections of murine tissues.

Tobias Böhmer1, Norbert Pfeiffer, Adrian Gericke.   

Abstract

We tested the specificity of three commercially available antibodies (AB) against individual α1-adrenergic receptor subtypes (α1-ARST). We used these ABs to localize the α1-ARST proteins by immunohistochemistry in paraffin-embedded murine tissues. The specificity of the ABs was tested by comparing staining patterns in tissues from wild-type mice with those in corresponding tissues from mice with gene-targeted disruption of the respective α1-ARST, one of the most rigorous negative controls. None of the tested ABs proved to be specific for the indicated target antigen. We conclude that the tested ABs are unsuitable for immunohistochemistry in paraffin-embedded murine tissues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24866500     DOI: 10.1007/s00210-014-0992-2

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

Review 1.  Controls for immunocytochemistry: an update.

Authors:  Richard W Burry
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

2.  Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor.

Authors:  A Cavalli; A L Lattion; E Hummler; M Nenniger; T Pedrazzini; J F Aubert; M C Michel; M Yang; G Lembo; C Vecchione; M Mostardini; A Schmidt; F Beermann; S Cotecchia
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors.

Authors:  Wisuit Pradidarcheep; Jan Stallen; Wil T Labruyère; Noshir F Dabhoiwala; Martin C Michel; Wouter H Lamers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-07       Impact factor: 3.000

4.  A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse.

Authors:  Craig J Daly; Clare Deighan; Ann McGee; Dawson Mennie; Zeeshan Ali; Melissa McBride; John C McGrath
Journal:  Physiol Genomics       Date:  2002-03-19       Impact factor: 3.107

5.  Functional alpha-1B adrenergic receptors on human epicardial coronary artery endothelial cells.

Authors:  Brian C Jensen; Philip M Swigart; Megan D Montgomery; Paul C Simpson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-09-22       Impact factor: 3.000

6.  Differential cardiovascular regulatory activities of the alpha 1B- and alpha 1D-adrenoceptor subtypes.

Authors:  Dan Chalothorn; Dan F McCune; Stephanie E Edelmann; Kimimasa Tobita; Bradley B Keller; Robert D Lasley; Dianne M Perez; Akito Tanoue; Gozoh Tsujimoto; Ginell R Post; Michael T Piascik
Journal:  J Pharmacol Exp Ther       Date:  2003-03-20       Impact factor: 4.030

7.  Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific.

Authors:  Brian C Jensen; Philip M Swigart; Paul C Simpson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-07       Impact factor: 3.000

8.  The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries.

Authors:  Brian C Jensen; Philip M Swigart; Marie-Eve Laden; Teresa DeMarco; Charles Hoopes; Paul C Simpson
Journal:  J Am Coll Cardiol       Date:  2009-09-22       Impact factor: 24.094

9.  Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure.

Authors:  D Gregg Rokosh; Paul C Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

10.  Alpha1A-adrenoceptors predominate in the control of blood pressure in mouse mesenteric vascular bed.

Authors:  S G Martínez-Salas; J M Campos-Peralta; J Pares-Hipolito; I A Gallardo-Ortíz; M Ibarra; R Villalobos-Molina
Journal:  Auton Autacoid Pharmacol       Date:  2007-07
View more
  11 in total

1.  Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.

Authors:  B A S Reyes; A F Carvalho; P Szot; D J Kalamarides; Q Wang; L G Kirby; E J Van Bockstaele
Journal:  Exp Neurol       Date:  2017-03-21       Impact factor: 5.330

2.  Naunyn-Schmiedeberg's Archives of Pharmacology under new editorship: change and continuity.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-24       Impact factor: 3.000

3.  Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent.

Authors:  Bat-Erdene Myagmar; James M Flynn; Patrick M Cowley; Philip M Swigart; Megan D Montgomery; Kevin Thai; Divya Nair; Rumita Gupta; David X Deng; Chihiro Hosoda; Simon Melov; Anthony J Baker; Paul C Simpson
Journal:  Circ Res       Date:  2017-02-20       Impact factor: 17.367

4.  Von Economo Neurons and Fork Cells: A Neurochemical Signature Linked to Monoaminergic Function.

Authors:  Anke A Dijkstra; Li-Chun Lin; Alissa L Nana; Stephanie E Gaus; William W Seeley
Journal:  Cereb Cortex       Date:  2018-01-01       Impact factor: 5.357

5.  Rat β₃-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues.

Authors:  Hana Cernecka; Wisuit Pradidarcheep; Wouter H Lamers; Martina Schmidt; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-30       Impact factor: 3.000

6.  A comparison of phosphospecific affinity reagents reveals the utility of recombinant Forkhead-associated domains in recognizing phosphothreonine-containing peptides.

Authors:  Leon A Venegas; Kritika Pershad; Oluwadamilola Bankole; Noman Shah; Brian K Kay
Journal:  N Biotechnol       Date:  2016-01-06       Impact factor: 5.079

7.  Commercially available antibodies directed against α-adrenergic receptor subtypes and other G protein-coupled receptors with acceptable selectivity in flow cytometry experiments.

Authors:  Abhishek Tripathi; Vadim Gaponenko; Matthias Majetschak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-14       Impact factor: 3.000

Review 8.  Nuclear compartmentalization of α1-adrenergic receptor signaling in adult cardiac myocytes.

Authors:  Steven C Wu; Timothy D OʼConnell
Journal:  J Cardiovasc Pharmacol       Date:  2015-02       Impact factor: 3.105

9.  Antidepressants Differentially Regulate Intracellular Signaling from α1-Adrenergic Receptor Subtypes In Vitro.

Authors:  Piotr Chmielarz; Justyna Kuśmierczyk; Katarzyna Rafa-Zabłocka; Katarzyna Chorązka; Marta Kowalska; Grzegorz Satała; Irena Nalepa
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

10.  Cardiac and Vascular α1-Adrenoceptors in Congestive Heart Failure: A Systematic Review.

Authors:  Gizem Kaykı-Mutlu; Olga Papazisi; Meindert Palmen; A H Jan Danser; Martin C Michel; Ebru Arioglu-Inan
Journal:  Cells       Date:  2020-11-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.